Xingliang Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xingliang Zhou has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Qi-Long Ying
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, USA
6 shared publications Shoudong Ye
Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, University of Southern California, Los Angeles, CA 90033, USA; Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University, Hefei 230601, PRC
3 shared publicationsBryan Ruiz
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
2 shared publicationsDahai Liu
Center for Stem Cell and Translational Medicine, School of Life Sciences, Anhui University, Hefei 230601, PRC
2 shared publicationsGuanyi Huang
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology &Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
2 shared publicationsChang Tong
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, Department of Stem Cell Biology &Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
1 shared publication
Latest Publications
- Open Access
- 1 September 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 9 (3) , 732-741
Cytoplasmic and Nuclear TAZ Exert Distinct Functions in Regulating Primed Pluripotency
- 1 September 2017
- Published by Elsevier in Stem Cell Reports
- Vol. 9 (3) , 732-741
Open AccessCytoplasmic and Nuclear TAZ Exert Distinct Functions in Regulating Primed Pluripotency
- Open Access
- 22 February 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 21918
Induction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9
Chromosomal translocation is the most common form of chromosomal abnormality and is often associated with congenital genetic disorders, infertility and cancers. The lack of cellular and animal models for chromosomal translocations, however, has hampered our ability to understand the underlying disease mechanisms and to develop new therapies. Here, we show that site-specific chromosomal translocations can be generated in mouse embryonic stem cells (mESCs) via CRISPR/Cas9. Mouse ESCs carrying translocated chromosomes can be isolated and expanded to establish stable cell lines. Furthermore, chimeric mice can be generated by injecting these mESCs into host blastocysts. The establishment of ESC-based cellular and animal models of chromosomal translocation by CRISPR/Cas9 provides a powerful platform for understanding the effect of chromosomal translocation and for the development of new therapeutic strategies.
- 22 February 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 21918
Open AccessInduction of site-specific chromosomal translocations in embryonic stem cells by CRISPR/Cas9
Chromosomal translocation is the most common form of chromosomal abnormality and is often associated with congenital genetic disorders, infertility and cancers. The lack of cellular and animal models for chromosomal translocations, however, has hampered our ability to understand the underlying disease mechanisms and to develop new therapies. Here, we show that site-specific chromosomal translocations can be generated in mouse embryonic stem cells (mESCs) via CRISPR/Cas9. Mouse ESCs carrying translocated chromosomes can be isolated and expanded to establish stable cell lines. Furthermore, chimeric mice can be generated by injecting these mESCs into host blastocysts. The establishment of ESC-based cellular and animal models of chromosomal translocation by CRISPR/Cas9 provides a powerful platform for understanding the effect of chromosomal translocation and for the development of new therapeutic strategies.
- 1 October 2015
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 34, 1-9
New insights into the conserved mechanism of pluripotency maintenance
- 1 October 2015
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 34, 1-9
New insights into the conserved mechanism of pluripotency maintenance
- Open Access
- 1 September 2015
- Published by Elsevier in Stem Cell Reports
- Vol. 5 (3) , 314-322
Klf2 and Tfcp2l1, Two Wnt/β-Catenin Targets, Act Synergistically to Induce and Maintain Naive Pluripotency
- 1 September 2015
- Published by Elsevier in Stem Cell Reports
- Vol. 5 (3) , 314-322
Open AccessKlf2 and Tfcp2l1, Two Wnt/β-Catenin Targets, Act Synergistically to Induce and Maintain Naive Pluripotency
- 17 January 2015
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 72 (9) , 1741-1757
Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network
Embryonic stem cells (ESCs) can be maintained in culture indefinitely while retaining the capacity to generate any type of cell in the body, and therefore not only hold great promise for tissue repair and regeneration, but also provide a powerful tool for modeling human disease and understanding biological development. In order to fulfill the full potential of ESCs, it is critical to understand how ESC fate, whether to self-renew or to differentiate into specialized cells, is regulated. On the molecular level, ESC fate is controlled by the intracellular transcriptional regulatory networks that respond to various extrinsic signaling stimuli. In this review, we discuss and compare important signaling pathways in the self-renewal and differentiation of mouse, rat, and human ESCs with an emphasis on how these pathways integrate into ESC-specific transcription circuitries. This will be beneficial for understanding the common and conserved mechanisms that govern self-renewal, and for developing novel culture conditions that support ESC derivation and maintenance.
- 17 January 2015
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 72 (9) , 1741-1757
Molecular basis of embryonic stem cell self-renewal: from signaling pathways to pluripotency network
Embryonic stem cells (ESCs) can be maintained in culture indefinitely while retaining the capacity to generate any type of cell in the body, and therefore not only hold great promise for tissue repair and regeneration, but also provide a powerful tool for modeling human disease and understanding biological development. In order to fulfill the full potential of ESCs, it is critical to understand how ESC fate, whether to self-renew or to differentiate into specialized cells, is regulated. On the molecular level, ESC fate is controlled by the intracellular transcriptional regulatory networks that respond to various extrinsic signaling stimuli. In this review, we discuss and compare important signaling pathways in the self-renewal and differentiation of mouse, rat, and human ESCs with an emphasis on how these pathways integrate into ESC-specific transcription circuitries. This will be beneficial for understanding the common and conserved mechanisms that govern self-renewal, and for developing novel culture conditions that support ESC derivation and maintenance.
- Open Access
- 29 August 2013
- Published by Springer Nature in Nature Communications
- Vol. 4 (1) , 2403
Modulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal
Wnt/β-catenin signalling has a variety of roles in regulating stem cell fates. Its specific role in mouse epiblast stem cell self-renewal, however, remains poorly understood. Here we show that Wnt/β-catenin functions in both self-renewal and differentiation in mouse epiblast stem cells. Stabilization and nuclear translocation of β-catenin and its subsequent binding to T-cell factors induces differentiation. Conversely, retention of stabilized β-catenin in the cytoplasm maintains self-renewal. Cytoplasmic retention of β-catenin is effected by stabilization of Axin2, a downstream target of β-catenin, or by genetic modifications to β-catenin that prevent its nuclear translocation. We also find that human embryonic stem cell and mouse epiblast stem cell fates are regulated by β-catenin through similar mechanisms. Our results elucidate a new role for β-catenin in stem cell self-renewal that is independent of its transcriptional activity and will have broad implications in understanding the molecular regulation of stem cell fate.
- 29 August 2013
- Published by Springer Nature in Nature Communications
- Vol. 4 (1) , 2403
Open AccessModulation of β-catenin function maintains mouse epiblast stem cell and human embryonic stem cell self-renewal
Wnt/β-catenin signalling has a variety of roles in regulating stem cell fates. Its specific role in mouse epiblast stem cell self-renewal, however, remains poorly understood. Here we show that Wnt/β-catenin functions in both self-renewal and differentiation in mouse epiblast stem cells. Stabilization and nuclear translocation of β-catenin and its subsequent binding to T-cell factors induces differentiation. Conversely, retention of stabilized β-catenin in the cytoplasm maintains self-renewal. Cytoplasmic retention of β-catenin is effected by stabilization of Axin2, a downstream target of β-catenin, or by genetic modifications to β-catenin that prevent its nuclear translocation. We also find that human embryonic stem cell and mouse epiblast stem cell fates are regulated by β-catenin through similar mechanisms. Our results elucidate a new role for β-catenin in stem cell self-renewal that is independent of its transcriptional activity and will have broad implications in understanding the molecular regulation of stem cell fate.